Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 22-Mar-24 1:30 PM View:  | Bryan Nancy Director | Hemispherx Biopharma, Inc. (AIM) | 21-Mar-24 | Private Purchase | 38,462 | $0.39 | $15,000.20 | 100% 0 to 38.46K | |
| 18-Mar-24 3:01 PM View: | Appelrouth Stewart Director | Hemispherx Biopharma, Inc. (AIM) | 15-Mar-24 | Private Purchase | 90,910 | $0.33 | $30,000.30 | 61% 148.85K to 239.76K | |
| 18-Mar-24 3:01 PM View: | Equels Thomas K. CEO & President Director | Hemispherx Biopharma, Inc. (AIM) | 15-Mar-24 | Private Purchase | 75,758 | $0.33 | $25,000.10 | 12% 640.7K to 716.46K | |
| 18-Mar-24 3:01 PM View: | Rodino Peter W. III COO, Secretary, Gen. Counsel | Hemispherx Biopharma, Inc. (AIM) | 15-Mar-24 | Private Purchase | 37,879 | $0.33 | $12,500.10 | 26% 143.84K to 181.72K | |
| 27-Nov-23 12:56 PM View: | Equels Thomas K. CEO & President Director | Hemispherx Biopharma, Inc. (AIM) | 27-Nov-23 | Private Purchase | 33,861 | $0.44 | $15,000.40 | 6% 606.84K to 640.7K | |
| 29-Sep-23 3:29 PM View: | Equels Thomas K. CEO & President Director | Hemispherx Biopharma, Inc. (AIM) | 29-Sep-23 | Private Purchase | 22,676 | $0.44 | $10,000.10 | 4% 584.16K to 606.84K | |
| 25-Aug-23 2:26 PM View: | Equels Thomas K. CEO & President Director | Hemispherx Biopharma, Inc. (AIM) | 25-Aug-23 | Private Purchase | 8,222 | $0.67 | $5,500.52 | 1% 575.94K to 584.16K | |
| 24-Aug-23 1:52 PM View: | Equels Thomas K. CEO & President Director | Hemispherx Biopharma, Inc. (AIM) | 24-Aug-23 | Private Purchase | 14,993 | $0.67 | $10,000.30 | 3% 560.95K to 575.94K | |
| 17-Jul-23 7:20 PM View: | Equels Thomas K. CEO & President Director | Hemispherx Biopharma, Inc. (AIM) | 17-Jul-23 | Private Purchase | 16,950 | $0.59 | $10,000.50 | 3% 544.0K to 560.95K | |
| 10-Mar-23 4:05 PM View: | Appelrouth Stewart Director | Hemispherx Biopharma, Inc. (AIM) | 10-Mar-23 | Disposition (other) | 68,208 | $1.23 | $83,895.80 | (31%) 217.06K to 148.85K | |
| 04-Jan-23 7:30 AM View: | Rodino Peter W. III COO, Secretary, Gen. Counsel | Hemispherx Biopharma, Inc. (AIM) | 03-Jan-23 | Private Purchase | 80,646 | $0.31 | $25,000.30 | 128% 63.19K to 143.84K | |
| 04-Jan-23 7:30 AM View: | Equels Thomas K. CEO & President Director | Hemispherx Biopharma, Inc. (AIM) | 03-Jan-23 | Private Purchase | 161,291 | $0.31 | $50,000.20 | 42% 382.7K to 544.0K | |
| 04-Jan-23 7:30 AM View: | Appelrouth Stewart Director | Hemispherx Biopharma, Inc. (AIM) | 03-Jan-23 | Private Purchase | 80,646 | $0.31 | $25,000.30 | 59% 136.42K to 217.06K | |
| 18-Jul-22 3:01 PM View: | Equels Thomas K. CEO & President Director | Hemispherx Biopharma, Inc. (AIM) | 18-Jul-22 | Grant | 32,895 | $0.76 | $25,000.20 | 9% 349.81K to 382.7K | |
| 26-Apr-22 8:42 AM View: | Rodino Peter W. III COO, Secretary, Gen. Counsel | Hemispherx Biopharma, Inc. (AIM) | 25-Apr-22 | Grant | 4,902 | $1.02 | $5,000.04 | 8% 58.29K to 63.19K | (11%) |
| 26-Apr-22 8:30 AM View: | Equels Thomas K. CEO & President Director | Hemispherx Biopharma, Inc. (AIM) | 25-Apr-22 | Grant | 49,020 | $1.02 | $50,000.40 | 16% 300.79K to 349.81K | (11%) |
| 27-Apr-22 3:46 PM View: | Appelrouth Stewart Director | Hemispherx Biopharma, Inc. (AIM) | 25-Apr-22 | Grant | 24,500 | $1.07 | $26,215.00 | 22% 111.92K to 136.42K | |
| 13-Dec-21 11:26 AM View: | Equels Thomas K. CEO & President Director | Hemispherx Biopharma, Inc. (AIM) | 13-Dec-21 | Grant | 21,552 | $1.16 | $25,000.30 | 8% 279.24K to 300.79K | (3%) |
| 10-Dec-21 10:55 AM View: | Equels Thomas K. CEO, President | Hemispherx Biopharma, Inc. (AIM) | 10-Dec-21 | Grant | 11,811 | $1.27 | $15,000.00 | 4% 267.43K to 279.24K | (9%) |
| 24-Nov-21 1:51 PM View: | Equels Thomas K. CEO & President Director | Hemispherx Biopharma, Inc. (AIM) | 24-Nov-21 | Grant | 11,627 | $1.29 | $14,998.80 | 5% 255.8K to 267.43K | 0% |
| 24-Nov-21 1:57 PM View: | Appelrouth Stewart Director | Hemispherx Biopharma, Inc. (AIM) | 24-Nov-21 | Grant | 19,379 | $1.29 | $24,998.90 | 21% 92.54K to 111.92K | 6% |
| 23-Nov-21 11:08 AM View: | Equels Thomas K. CEO & President Director | Hemispherx Biopharma, Inc. (AIM) | 23-Nov-21 | Grant | 11,194 | $1.34 | $15,000.00 | 5% 244.6K to 255.8K | (11%) |
| 19-Nov-21 11:28 AM View: | Equels Thomas K. CEO & President Director | Hemispherx Biopharma, Inc. (AIM) | 19-Nov-21 | Grant | 10,204 | $1.47 | $14,999.90 | 4% 234.4K to 244.6K | (21%) |
| 17-Nov-21 5:27 PM View: | Equels Thomas K. CEO & President Director | Hemispherx Biopharma, Inc. (AIM) | 17-Nov-21 | Grant | 9,146 | $1.64 | $14,999.40 | 4% 225.25K to 234.4K | (27%) |
| 16-Jul-21 12:07 PM View: | Equels Thomas K. CEO & President Director | Hemispherx Biopharma, Inc. (AIM) | 16-Jul-21 | Market Purchase | 15,625 | $1.92 | $30,000.00 | 7% 209.63K to 225.25K | (38%) |
| 25-Feb-21 3:07 PM View: | Appelrouth Stewart Director | Hemispherx Biopharma, Inc. (AIM) | 25-Feb-21 | Market Purchase | 10,638 | $2.35 | $24,999.30 | 13% 81.9K to 92.54K | (50%) |
| 24-Feb-21 12:03 PM View: | Equels Thomas K. CEO & President Director | Hemispherx Biopharma, Inc. (AIM) | 24-Feb-21 | Market Purchase | 11,062 | $2.26 | $25,000.10 | 6% 198.57K to 209.63K | (48%) |
| 17-Dec-20 12:22 PM View: | Equels Thomas K. CEO Director | Hemispherx Biopharma, Inc. (AIM) | 17-Dec-20 | Market Purchase | 14,535 | $1.72 | $25,000.20 | 8% 184.03K to 198.57K | (31%) |
| 03-Sep-20 10:53 AM View: | Equels Thomas K. CEO & President Director | Hemispherx Biopharma, Inc. (AIM) | 03-Sep-20 | Market Purchase | 12,316 | $2.03 | $25,001.50 | 7% 171.72K to 184.03K | (43%) |
| 21-Aug-20 8:08 AM View: | Equels Thomas K. CEO Director | Hemispherx Biopharma, Inc. (AIM) | 21-Aug-20 | Market Purchase | 10,730 | $2.33 | $25,000.90 | 7% 160.99K to 171.72K | (51%) |
| 02-Jan-20 11:07 AM View: | Rodino Peter W. III Dir Govt Relations/Sectry | Hemispherx Biopharma, Inc. (AIM) | 31-Dec-19 | Grant | 6,879 | $0.53 | $3,645.87 | 13% 51.41K to 58.29K | 104% |
| 02-Jan-20 11:34 AM View: | Lintal Ellen M CFO | Hemispherx Biopharma, Inc. (AIM) | 31-Dec-19 | Grant | 3,931 | $0.53 | $2,083.43 | 21% 18.96K to 22.89K | 104% |
| 02-Jan-20 10:47 AM View: | Equels Thomas K. Exec.Vice Chairman/CEO/Pres. Director | Hemispherx Biopharma, Inc. (AIM) | 31-Dec-19 | Grant | 14,741 | $0.53 | $7,812.73 | 10% 146.25K to 160.99K | 104% |
| 16-Dec-19 1:15 PM View: | Mitchell William M Director | Hemispherx Biopharma, Inc. (AIM) | 13-Dec-19 | Acquisition (other) | 8,358 | $0.45 | $3,801.22 | 12% 68.05K to 76.41K | 137% |
| 16-Dec-19 10:07 AM View: | Lintal Ellen M CFO | Hemispherx Biopharma, Inc. (AIM) | 13-Dec-19 | Grant | 4,789 | $0.44 | $2,083.22 | 34% 14.17K to 18.96K | 148% |
| 16-Dec-19 1:28 PM View: | Appelrouth Stewart Director | Hemispherx Biopharma, Inc. (AIM) | 13-Dec-19 | Acquisition (other) | 8,358 | $0.45 | $3,801.22 | 11% 72.97K to 81.33K | 137% |
| 16-Dec-19 9:25 AM View: | Equels Thomas K. Exec.Vice Chairman/CEO/Pres. Director | Hemispherx Biopharma, Inc. (AIM) | 13-Dec-19 | Grant | 17,960 | $0.44 | $7,812.60 | 14% 128.29K to 146.25K | 148% |
| 16-Dec-19 9:40 AM View: | Rodino Peter W. III Dir Govt Relations/Sectry | Hemispherx Biopharma, Inc. (AIM) | 13-Dec-19 | Grant | 8,381 | $0.44 | $3,645.74 | 19% 43.03K to 51.41K | 148% |
| 02-Dec-19 11:48 AM View: | Equels Thomas K. Exec.Vice Chairman/CEO/Pres. Director | Hemispherx Biopharma, Inc. (AIM) | 29-Nov-19 | Grant | 19,531 | $0.40 | $7,812.40 | 18% 108.76K to 128.29K | 200% |
| 02-Dec-19 12:09 PM View: | Rodino Peter W. III Dir Govt Relations/Sectry | Hemispherx Biopharma, Inc. (AIM) | 29-Nov-19 | Grant | 9,115 | $0.40 | $3,646.00 | 27% 33.91K to 43.03K | 200% |
| 02-Dec-19 12:43 PM View: | Mitchell William M Director | Hemispherx Biopharma, Inc. (AIM) | 29-Nov-19 | Acquisition (other) | 9,503 | $0.40 | $3,801.20 | 16% 58.55K to 68.05K | 200% |
| 02-Dec-19 12:28 PM View: | Lintal Ellen M CFO | Hemispherx Biopharma, Inc. (AIM) | 29-Nov-19 | Grant | 5,208 | $0.40 | $2,083.20 | 58% 8.96K to 14.17K | 200% |
| 02-Dec-19 12:57 PM View: | Appelrouth Stewart Director | Hemispherx Biopharma, Inc. (AIM) | 29-Nov-19 | Acquisition (other) | 9,503 | $0.40 | $3,801.20 | 15% 63.47K to 72.97K | 200% |
| 18-Nov-19 2:51 PM View: | Rodino Peter W. III Dir Govt Relations/Sectry | Hemispherx Biopharma, Inc. (AIM) | 15-Nov-19 | Grant | 7,752 | $0.47 | $3,643.44 | 30% 26.16K to 33.91K | 194% |
| 18-Nov-19 4:11 PM View: | Mitchell William M Director | Hemispherx Biopharma, Inc. (AIM) | 15-Nov-19 | Acquisition (other) | 8,264 | $0.46 | $3,801.44 | 16% 50.28K to 58.55K | 200% |
| 18-Nov-19 3:07 PM View: | Lintal Ellen M CFO | Hemispherx Biopharma, Inc. (AIM) | 15-Nov-19 | Grant | 4,433 | $0.47 | $2,083.51 | 98% 4.53K to 8.96K | 194% |
| 18-Nov-19 4:22 PM View: | Appelrouth Stewart Director | Hemispherx Biopharma, Inc. (AIM) | 15-Nov-19 | Acquisition (other) | 8,264 | $0.46 | $3,801.44 | 15% 55.2K to 63.47K | 200% |
| 18-Nov-19 2:30 PM View: | Equels Thomas K. Exec.Vice Chairman/CEO/Pres. Director | Hemispherx Biopharma, Inc. (AIM) | 15-Nov-19 | Grant | 16,622 | $0.47 | $7,812.34 | 18% 92.14K to 108.76K | 194% |
| 01-Nov-19 10:48 AM View: | Mitchell William M Director | Hemispherx Biopharma, Inc. (AIM) | 31-Oct-19 | Acquisition (other) | 7,603 | $0.50 | $3,801.50 | 18% 42.68K to 50.28K | 140% |
| 31-Oct-19 2:28 PM View: | Lintal Ellen M CFO | Hemispherx Biopharma, Inc. (AIM) | 31-Oct-19 | Grant | 4,167 | $0.50 | $2,083.50 | 1145% 0.36K to 4.53K | 140% |
